ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
P. Michael McFadden
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prasad, A.
Right arrow Articles by McFadden, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prasad, A.
Right arrow Articles by McFadden, P. M.

Ann Thorac Surg 1999;68:1840-1841
© 1999 The Society of Thoracic Surgeons

Case Reports

Cardiac allograft valvulopathy: a case of donor-anorexigen-induced valvular disease

Ananth Prasad, MDa, Mandeep Mehra, MDa, Myung Park, MDa, Robert Scott, MD, PhDa, Patricia A. Uber, Pharm Da, P. Michael McFadden, MDa

a Ochsner Cardiomyopathy and Heart Transplantation Center, Ochsner Medical Institutions, New Orleans, Louisiana, USA

Address reprint requests to Dr Mehra, Division of Cardiothoracic Surgery, Ochsner Clinic, 1514 Jefferson Highway, New Orleans, LA 70121;
e-mail: hrttpl{at}aol.com

We report on the transplantation of a cardiac allograft from a donor with prolonged exposure to anorexigens. This event allowed us to not only examine the early pathological alterations that characterize anorexigen-induced valvular damage, but to also study the posttransplantation outcome after the donor heart had been removed from the offending milieu. A donor history of anorexigen use should be sought, and if detected, careful evaluation for underlying valvular disease should be entertained. Early valvulopathy may appear clinically mild yet pathologically significant. Our single-case experience also suggests that anorexigen-induced valvulopathy may be a progressive disorder despite removal of the heart from the causative environment.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
T. O. Cheng
Reversibility of anorexigenic valvulopathy
Ann. Thorac. Surg., January 1, 2001; 71(1): 397 - 397.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 by The Society of Thoracic Surgeons.